parthenolide has been researched along with Bile Duct Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, DG; Kim, JH; Kim, YT; Lee, SO; Liu, L; You, KR | 1 |
1 other study(ies) available for parthenolide and Bile Duct Cancer
Article | Year |
---|---|
Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Cytochromes c; Drug Resistance, Neoplasm; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Membrane Potentials; Mitochondria; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sesquiterpenes; Tumor Suppressor Protein p53 | 2005 |